verified SJR 8,529 · Q1 • database Scopus / SJR & Web of Science indexed

Netherlands · Elsevier B.V.

workspace_premium Q1 — Urology lock Subscription

European Urology

European Urology is a journal indexed in SJR in Urology with an H index of 274. It has an SJR impact factor of 8,529 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 8,529.

European Urology focuses its scope in these topics and keywords: cancer, prostate, patients, urol, treatment, eur, systematic, review, surveillance, bladder, ...

ISSN: 0302-2838

Publisher: Elsevier B.V.

Category: Urology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

8,529 Q1

H-index 274

Acceptance rate pie_chart

19% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

8,529

H-index

274

Docs (year)

394

Docs 3y

1137

Total refs

5836

Cites 3y

8380

Citable 3y

344

Cites/Doc 2y

6.96

Ref/Doc

14.81

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Comorbidity Assessment in Localized Prostate Cancer: A Review of Currently Available Techniques

Value of a Statistical Model Based on Four Kallikrein Markers in Blood, Commercially Available as 4Kscore, in All Reasonable Prostate Biopsy Subgroups

Innovations in Serum and Urine Markers in Prostate Cancer

Hyperbaric Oxygen for the Treatment of Interstitial Cystitis: Long-Term Results of a Prospective Pilot Study

Handling and Pathology Reporting of Adrenal Gland Specimens

Genetic Profile of Bone Metastases in Renal Cell Carcinoma

FSH in testis cancer

Evaluation of the Clinical Benefit of Permixon and Tamsulosin in Severe BPH Patients - PERMAL Study Subset Analysis

European Association of Urology Guidelines on Priapism

Engineered FGF-2 Expression Induces Glandular Epithelial Hyperplasia in the Murine Prostatic Dorsal Lobe

Endoscopic Treatment of Vesicoureteral Reflux with Polydimethylsiloxane in Adult Women

Cytostatic and Apoptotic Effects of Bisphosphonates on Prostate Cancer Cells

SHOW MORE ARTICLES

Conservative Management of Mucosal Prostatic Urethral Involvement in Patients with Superficial Transitional Cell Carcinoma of the Bladder

A Multicenter, Randomized, Double-Blind, Crossover Study to Evaluate Patient Preference between Tadalafil and Sildenafil

Clinical Outcomes from Androgen Signaling-directed Therapy after Treatment with Abiraterone Acetate and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302

Clinical Correlation of Prostatic Lithiasis with Chronic Pelvic Pain Syndromes in Young Adults

Chromosomal High-Polysomies Predict Tumour Progression in T1 Transitional Cell Carcinoma of the Bladder

Celecoxib has Potent Antitumour Effects as a Single Agent and in Combination with BCG Immunotherapy in a Model of Urothelial Cell Carcinoma

Bladder C-Fiber Desensitization Induces a Long-Lasting Improvement of BPH-Associated Storage LUTS: A Pilot Study

Biopsy of the Red Patch at Cystoscopy: Is It Worthwhile?

BCG Intravesical Instillations: Recommendations for Side-Effects Management

Adherence to an Annual PSA Screening Program over 3 Years for Brothers and Sons of Men with Prostate Cancer

Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy Specimens

A Vaccination Strategy for the Long-Term Suppression of Androgens in Advanced Prostate Cancer

FAQs

European Urology has an SJR of 8,529 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for European Urology is 19%.

European Urology

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of European Urology?

What is the APC / publication cost?

What is the acceptance rate?